MyFinsight
Home
Blog
About
Proceeds from sales of
common stock
$5,084K
(166.60%↑ Y/Y)
Exercise of common stock
warrants
$39K
Net cash provided by
financing activities
$4,901K
(161.11%↑ Y/Y)
Canceled cashflow
$222K
Net change in cash
and cash...
$3,166K
(327.61%↑ Y/Y)
Canceled cashflow
$1,735K
Issuance costs of sale of
common stock
$222K
(640.00%↑ Y/Y)
Reduction in the carrying
amount of right-of-use...
$121K
(-38.27%↓ Y/Y)
Share-based compensation
$109K
(-59.33%↓ Y/Y)
Accrued expenses and
other current...
$20K
(-95.52%↓ Y/Y)
Prepaid expenses and
other current assets
-$18K
(57.14%↑ Y/Y)
Depreciation
$3K
(-82.35%↓ Y/Y)
Net cash used in
operating activities
-$1,735K
(46.89%↑ Y/Y)
Canceled cashflow
$271K
Net loss
-$1,613K
(66.12%↑ Y/Y)
Payable
-$255K
(-134.41%↓ Y/Y)
Operating lease liability
-$128K
(37.86%↑ Y/Y)
Receivable
$10K
(0.00%↑ Y/Y)
Back
Back
Cash Flow
BioCardia, Inc. (BCDA)
BioCardia, Inc. (BCDA)
source: myfinsight.com